Effect of statins on atrial fibrillation

collaborative meta-analysis of published and unpublished evidence from randomised controlled trials.

K. Rahimi, Joanthan Emberson, P McGale , Sandawana William Majoni, A Merhi , F W. Asselbergs, Vera Krane, P W. Macfarlane

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Objective: To examine whether statins can reduce the risk of atrial fibrillation.

Design: Meta-analysis of published and unpublished results from larger scale statin trials, with comparison of the findings against the published results from smaller scale or shorter duration studies.

Data sources: Medline, Embase, and Cochrane’s CENTRAL up to October 2010. Unpublished data from longer term trials were obtained through contact with investigators.

Study selection: Randomised controlled trials comparing statin with no statin or comparing high dose versus standard dose statin; all longer term trials had at least 100 participants and at least six months’ follow-up.

Results: In published data from 13 short term trials (4414 randomised patients, 659 events), statin treatment seemed to reduce the odds of an episode of atrial fibrillation by 39% (odds ratio 0.61, 95% confidence interval 0.51 to 0.74; P<0.001), but there was significant heterogeneity (P<0.001) between the trials. In contrast, among 22 longer term and mostly larger trials of statin versus control (105 791 randomised patients, 2535 events), statin treatment was not associated with a significant reduction in atrial fibrillation (0.95, 0.88 to 1.03; P=0.24) (P<0.001 for test of difference between the two sets of trials). Seven longer term trials of more intensive versus standard statin regimens (28 964 randomised patients and 1419 events) also showed no evidence of a reduction in the risk of atrial fibrillation (1.00, 0.90 to 1.12; P=0.99).

Conclusions: The suggested beneficial effect of statins on atrial fibrillation from published shorter term studies is not supported by a comprehensive review of published and unpublished evidence from larger scale trials.

Original languageEnglish
Article numberd1250
Pages (from-to)1-11
Number of pages11
JournalBritish Medical Journal
Volume342
DOIs
Publication statusPublished - 2011
Externally publishedYes

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Atrial Fibrillation
Meta-Analysis
Randomized Controlled Trials
Information Storage and Retrieval
Risk Reduction Behavior
Odds Ratio
Research Personnel
Confidence Intervals

Cite this

Rahimi, K., Emberson, J., McGale , P., Majoni, S. W., Merhi , A., W. Asselbergs, F., ... W. Macfarlane, P. (2011). Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials. British Medical Journal, 342, 1-11. [d1250]. https://doi.org/10.1136/bmj.d1250
Rahimi, K. ; Emberson, Joanthan ; McGale , P ; Majoni, Sandawana William ; Merhi , A ; W. Asselbergs, F ; Krane, Vera ; W. Macfarlane, P. / Effect of statins on atrial fibrillation : collaborative meta-analysis of published and unpublished evidence from randomised controlled trials. In: British Medical Journal. 2011 ; Vol. 342. pp. 1-11.
@article{0e16a815d932467f8b6061a868003d4f,
title = "Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials.",
abstract = "Objective: To examine whether statins can reduce the risk of atrial fibrillation.Design: Meta-analysis of published and unpublished results from larger scale statin trials, with comparison of the findings against the published results from smaller scale or shorter duration studies.Data sources: Medline, Embase, and Cochrane’s CENTRAL up to October 2010. Unpublished data from longer term trials were obtained through contact with investigators.Study selection: Randomised controlled trials comparing statin with no statin or comparing high dose versus standard dose statin; all longer term trials had at least 100 participants and at least six months’ follow-up.Results: In published data from 13 short term trials (4414 randomised patients, 659 events), statin treatment seemed to reduce the odds of an episode of atrial fibrillation by 39{\%} (odds ratio 0.61, 95{\%} confidence interval 0.51 to 0.74; P<0.001), but there was significant heterogeneity (P<0.001) between the trials. In contrast, among 22 longer term and mostly larger trials of statin versus control (105 791 randomised patients, 2535 events), statin treatment was not associated with a significant reduction in atrial fibrillation (0.95, 0.88 to 1.03; P=0.24) (P<0.001 for test of difference between the two sets of trials). Seven longer term trials of more intensive versus standard statin regimens (28 964 randomised patients and 1419 events) also showed no evidence of a reduction in the risk of atrial fibrillation (1.00, 0.90 to 1.12; P=0.99).Conclusions: The suggested beneficial effect of statins on atrial fibrillation from published shorter term studies is not supported by a comprehensive review of published and unpublished evidence from larger scale trials.",
author = "K. Rahimi and Joanthan Emberson and P McGale and Majoni, {Sandawana William} and A Merhi and {W. Asselbergs}, F and Vera Krane and {W. Macfarlane}, P",
year = "2011",
doi = "10.1136/bmj.d1250",
language = "English",
volume = "342",
pages = "1--11",
journal = "British Medical Journal",
issn = "0959-535X",
publisher = "British Medical Journal Publishing Group (BMJ Publishing)",

}

Rahimi, K, Emberson, J, McGale , P, Majoni, SW, Merhi , A, W. Asselbergs, F, Krane, V & W. Macfarlane, P 2011, 'Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials.', British Medical Journal, vol. 342, d1250, pp. 1-11. https://doi.org/10.1136/bmj.d1250

Effect of statins on atrial fibrillation : collaborative meta-analysis of published and unpublished evidence from randomised controlled trials. / Rahimi, K.; Emberson, Joanthan; McGale , P; Majoni, Sandawana William; Merhi , A; W. Asselbergs, F; Krane, Vera; W. Macfarlane, P.

In: British Medical Journal, Vol. 342, d1250, 2011, p. 1-11.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Effect of statins on atrial fibrillation

T2 - collaborative meta-analysis of published and unpublished evidence from randomised controlled trials.

AU - Rahimi, K.

AU - Emberson, Joanthan

AU - McGale , P

AU - Majoni, Sandawana William

AU - Merhi , A

AU - W. Asselbergs, F

AU - Krane, Vera

AU - W. Macfarlane, P

PY - 2011

Y1 - 2011

N2 - Objective: To examine whether statins can reduce the risk of atrial fibrillation.Design: Meta-analysis of published and unpublished results from larger scale statin trials, with comparison of the findings against the published results from smaller scale or shorter duration studies.Data sources: Medline, Embase, and Cochrane’s CENTRAL up to October 2010. Unpublished data from longer term trials were obtained through contact with investigators.Study selection: Randomised controlled trials comparing statin with no statin or comparing high dose versus standard dose statin; all longer term trials had at least 100 participants and at least six months’ follow-up.Results: In published data from 13 short term trials (4414 randomised patients, 659 events), statin treatment seemed to reduce the odds of an episode of atrial fibrillation by 39% (odds ratio 0.61, 95% confidence interval 0.51 to 0.74; P<0.001), but there was significant heterogeneity (P<0.001) between the trials. In contrast, among 22 longer term and mostly larger trials of statin versus control (105 791 randomised patients, 2535 events), statin treatment was not associated with a significant reduction in atrial fibrillation (0.95, 0.88 to 1.03; P=0.24) (P<0.001 for test of difference between the two sets of trials). Seven longer term trials of more intensive versus standard statin regimens (28 964 randomised patients and 1419 events) also showed no evidence of a reduction in the risk of atrial fibrillation (1.00, 0.90 to 1.12; P=0.99).Conclusions: The suggested beneficial effect of statins on atrial fibrillation from published shorter term studies is not supported by a comprehensive review of published and unpublished evidence from larger scale trials.

AB - Objective: To examine whether statins can reduce the risk of atrial fibrillation.Design: Meta-analysis of published and unpublished results from larger scale statin trials, with comparison of the findings against the published results from smaller scale or shorter duration studies.Data sources: Medline, Embase, and Cochrane’s CENTRAL up to October 2010. Unpublished data from longer term trials were obtained through contact with investigators.Study selection: Randomised controlled trials comparing statin with no statin or comparing high dose versus standard dose statin; all longer term trials had at least 100 participants and at least six months’ follow-up.Results: In published data from 13 short term trials (4414 randomised patients, 659 events), statin treatment seemed to reduce the odds of an episode of atrial fibrillation by 39% (odds ratio 0.61, 95% confidence interval 0.51 to 0.74; P<0.001), but there was significant heterogeneity (P<0.001) between the trials. In contrast, among 22 longer term and mostly larger trials of statin versus control (105 791 randomised patients, 2535 events), statin treatment was not associated with a significant reduction in atrial fibrillation (0.95, 0.88 to 1.03; P=0.24) (P<0.001 for test of difference between the two sets of trials). Seven longer term trials of more intensive versus standard statin regimens (28 964 randomised patients and 1419 events) also showed no evidence of a reduction in the risk of atrial fibrillation (1.00, 0.90 to 1.12; P=0.99).Conclusions: The suggested beneficial effect of statins on atrial fibrillation from published shorter term studies is not supported by a comprehensive review of published and unpublished evidence from larger scale trials.

U2 - 10.1136/bmj.d1250

DO - 10.1136/bmj.d1250

M3 - Article

VL - 342

SP - 1

EP - 11

JO - British Medical Journal

JF - British Medical Journal

SN - 0959-535X

M1 - d1250

ER -